Hyogo, Japan

Chiharu Kimura


Average Co-Inventor Count = 4.4

ph-index = 6

Forward Citations = 132(Granted Patents)


Location History:

  • Ibaraki, JP (1993 - 1994)
  • Maebashi, JP (1996)
  • Hyogo, JP (1998 - 2002)

Company Filing History:


Years Active: 1993-2002

Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Chiharu Kimura

Introduction

Chiharu Kimura, an accomplished inventor based in Hyogo, Japan, has made significant strides in the realm of pharmaceuticals with a focus on cyclic compounds. With a total of seven patents to her name, Kimura's work has implications for advanced therapeutic applications.

Latest Patents

Among her latest innovations, Kimura's patent titled "Cyclic compounds, their production and use" stands out. This invention encompasses novel compounds characterized by a specific general formula or salts thereof, showcasing a structure that includes a heterocyclic ring and the potential for various substituents. The compounds described exhibit excellent tachykinin receptor antagonistic effects, indicating valuable pharmaceutical applications.

Career Highlights

Chiharu Kimura is currently employed at Takeda Chemical Industries, Inc., a prominent global biotechnology company. Her career has been marked by a consistent dedication to research and development in the field of medicinal chemistry, leading to her notable contributions and innovations in pharmaceutical compounds.

Collaborations

Throughout her career, Kimura has collaborated with esteemed colleagues, including Hideaki Natsugari and Takenori Ishimaru. These collaborations have played a pivotal role in advancing her research and have contributed to her successful patent applications.

Conclusion

Chiharu Kimura's inventive spirit and dedication to pharmaceutical innovation illustrate the vital role of inventors in the scientific community. Her patents, particularly those related to cyclic compounds, not only highlight her expertise but also promise advancements in therapeutic strategies for various medical conditions. As she continues her work at Takeda Chemical Industries, her contributions will undoubtedly pave the way for future innovations in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…